Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results

Go back to Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results
(NASDAQ: NAGE) Delayed: 3.15 -0.02 (0.63%)
Previous Close $3.17    52 Week High
Open $3.17    52 Week Low
Day High $3.18    P/E N/A 
Day Low $3.08    EPS
Volume 431,908